Planet Labs PBC reported Q4 2025 revenue of $61.55 million, up 4.6% year-over-year and 0.5% sequentially, supported by a solid gross margin of 62.1%. Despite the revenue expansion, the company remains unprofitable on both an EBITDA and net income basis, with an EBITDA of -$10.09 million and a net loss of -$35.15 million for the quarter. Operating loss narrowed modestly versus prior periods as gross margin held up, but total operating expenses (R&D and SG&A) continue to pressure profitability. Free cash flow remained negative at -$19.30 million, and cash from operations was -$6.30 million, contributing to a cash balance of $129.99 million at period end. The balance sheet shows a robust liquidity position with low leverage: total debt of $21.6 million and net debt of -$96.4 million, while non-current and current deferred revenue totals point to meaningful prepayments from customers. The company traded at a price-to-sales multiple of approximately 6.4x and carrys a negative enterprise value multiple, reflecting investor focus on growth initiatives and the current profitability gap. Absent a material improvement in operating leverage or a step-up in recurring revenue contribution, Planet Labs faces a sustainability challenge in turning growth into sustained earnings. Investors should monitor contract wins, platform monetization, and cost discipline as key near-term catalysts.
Key Performance Indicators
Revenue
Increasing
61.55M
QoQ: 0.47% | YoY: 4.59%
Gross Profit
Increasing
38.22M
62.08% margin
QoQ: 1.86% | YoY: 17.65%
Operating Income
Increasing
-19.37M
QoQ: 14.34% | YoY: 42.90%
Net Income
Decreasing
-35.15M
QoQ: -75.06% | YoY: -16.85%
EPS
Decreasing
-0.12
QoQ: -75.18% | YoY: -9.09%
Revenue Trend
Margin Analysis
Financial Highlights
Revenue: $61.554 million for Q4 2025; YoY +4.59%, QoQ +0.47%.
Gross Profit: $38.215 million; Gross Margin 62.08% (YoY +17.65%, QoQ +1.86%).
Operating Income: -$19.366 million; Operating Margin -31.46% (YoY improvement but still negative; QoQ improvement of ~14.34%).
EBITDA: -$10.094 million; EBITDA Margin -16.40%.
Net Income: -$35.154 million; Net Margin -57.11% (YoY -16.85%, QoQ -75.06%).
EPS: -$0.12; Weighted Avg Shares 296.442 million.
Cash Flow: Operating cash flow -$6.295 million; Free cash Flow -$19.302 million.
Investing: Capital expenditures -$13.007 million; Purchases of investments -$34.658 million; Sales/maturities of investments $34.531 million; Net investing cash flow -$13.134 million.
Financing: Net cash change -$0.233 million from financing activities; Forex effect -$0.275 million.
Ending cash: $129.994 million; Beginning cash: $149.931 million.
Balance Sheet Highlights: Total assets $633.796 million; Total liabilities $192.510 million; Stockholders’ equity $441.286 million.
Liquidity: Current ratio 2.13; Quick ratio 2.13; Cash ratio 0.877.
Leverage and Returns: Net debt -$96.435 million; Debt-to-capitalization 4.67%; ROA -5.55%; ROE -7.97%; ROCE -3.94%.
Valuation: Price-to-Sales 6.41; Price-to-Book 0.89; Enterprise Value Multiple -4.83 (negative EV reflects debt and cash positioning).
Income Statement
Metric
Value
YoY Change
QoQ Change
Revenue
61.55M
4.59%
0.47%
Gross Profit
38.22M
17.65%
1.86%
Operating Income
-19.37M
42.90%
14.34%
Net Income
-35.15M
-16.85%
-75.06%
EPS
-0.12
-9.09%
-75.18%
Key Financial Ratios
Gross Profit Margin
Excellent
62.10%
Gross profit margin is exceptional, indicating strong pricing power and operational efficiency
Operating Profit Margin
Weak
-0.32%
Operating margin is below industry norms, profitability concerns
Net Profit Margin
Weak
-0.57%
Net profit margin is below industry norms, profitability concerns
Return on Assets
Weak
-0.06%
Return on assets suggests inefficient capital allocation
Return on Equity
Weak
-0.08%
Return on equity suggests inefficient capital allocation
Current Ratio
Healthy
2.13
Current ratio shows adequate liquidity to meet short-term obligations
Debt to Equity
Conservative
0.05
Debt-to-equity shows conservative leverage and low financial risk
P/E Ratio
Negative
-2.80x
Negative earnings make P/E ratio not meaningful
Price to Book
Undervalued
0.89x
Trading below book value, potential value opportunity or distressed
Management Insights Available for Members
Get exclusive access to management commentary, earnings call quotes, and forward guidance from company leadership.